
The United States Food and Drug Authority (FDA) has just given the green light to America’s first ever gene therapy treatment. It’s called Kymriah and it’s a genetically-modified autologous T-cell immunotherapy (CAR-T cell therapy). For the layman: individually customised, cancer-killing white blood cells. This is why it’s a big deal, and what the future could
read more...